Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Jaguar Health Inc.

    NASDAQ: JAGX · Real-Time Price · USD
    2.53
    -0.18 (-6.64%)
    At close: Jun 27, 2025, 3:59 PM
    2.62
    3.56%
    After-hours: Jun 27, 2025, 05:51 PM EDT

    Jaguar Health Statistics

    Share Statistics

    Jaguar Health has 1.32M shares outstanding. The number of shares has increased by -86.58% in one year.

    Shares Outstanding

    n/a
    		 1.32M

    Shares Change (YoY)

    n/a
    		 -86.58%

    Shares Change (QoQ)

    n/a
    		 39.02%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 1.09M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,089

    FTD / Avg. Volume

    n/a
    		 0.76%

    Short Selling Information

    The latest short interest is 28.79K, so 2.28% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 28.79K

    Short % of Shares Out

    n/a
    		 2.28%

    Short % of Float

    n/a
    		 2.33%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -0.19 and the forward PE ratio is -0.91. Jaguar Health's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.19

    Forward PE

    n/a
    		 -0.91

    PS Ratio

    n/a
    		 0.64

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 1.02

    P/FCF Ratio

    n/a
    		 -0.25

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Jaguar Health.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.63, with a Debt / Equity ratio of 5.01.

    Current Ratio

    n/a
    		 1.63

    Quick Ratio

    n/a
    		 1.11

    Debt / Equity

    n/a
    		 5.01

    Debt / EBITDA

    n/a
    		 -1

    Debt / FCF

    n/a
    		 -1.23

    Interest Coverage

    n/a
    		 -133.47

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $238,551.02

    Profits Per Employee

    n/a
    		 $-785,551.02

    Employee Count

    n/a
    		 49

    Asset Turnover

    n/a
    		 0.22

    Inventory Turnover

    n/a
    		 0.19

    Taxes

    Income Tax

    n/a
    		 -759K

    Effective Tax Rate

    n/a
    		 1.93%

    Stock Price Statistics

    The stock price has increased by -90.88% in the last 52 weeks. The beta is 0.69, so Jaguar Health's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.69

    52-Week Price Change

    n/a
    		 -90.88%

    50-Day Moving Average

    n/a
    		 6.03

    200-Day Moving Average

    n/a
    		 17.93

    Relative Strength Index (RSI)

    n/a
    		 28.76

    Average Volume (20 Days)

    n/a
    		 143,238

    Income Statement

    In the last 12 months, Jaguar Health had revenue of 11.69M and earned -38.49M in profits. Earnings per share was -130.69.

    Revenue

    n/a
    		 11.69M

    Gross Profit

    n/a
    		 9.73M

    Operating Income

    n/a
    		 -30.83M

    Net Income

    n/a
    		 -38.49M

    EBITDA

    n/a
    		 -36.66M

    EBIT

    n/a
    		 -39.02M

    Earnings Per Share (EPS)

    n/a
    		 -130.69
    Full Income Statement

    Balance Sheet

    The company has 8M in cash and 36.53M in debt, giving a net cash position of -28.52M.

    Cash & Cash Equivalents

    n/a
    		 8M

    Total Debt

    n/a
    		 36.53M

    Net Cash

    n/a
    		 -28.52M

    Retained Earnings

    n/a
    		 -346.48M

    Total Assets

    n/a
    		 51.46M

    Working Capital

    n/a
    		 2.23M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -29.38M and capital expenditures -231K, giving a free cash flow of -29.61M.

    Operating Cash Flow

    n/a
    		 -29.38M

    Capital Expenditures

    n/a
    		 -231K

    Free Cash Flow

    n/a
    		 -29.61M

    FCF Per Share

    n/a
    		 -100.55
    Full Cash Flow Statement

    Margins

    Gross margin is 83.27%, with operating and profit margins of -263.76% and -329.3%.

    Gross Margin

    n/a
    		 83.27%

    Operating Margin

    n/a
    		 -263.76%

    Pretax Margin

    n/a
    		 -335.79%

    Profit Margin

    n/a
    		 -329.3%

    EBITDA Margin

    n/a
    		 -313.65%

    EBIT Margin

    n/a
    		 -263.76%

    FCF Margin

    n/a
    		 -253.36%

    Dividends & Yields

    JAGX does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for JAGX is $60, which is 2073.9% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $60

    Price Target Difference

    n/a
    		 2073.9%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Mar 24, 2025. It was a backward split with a ratio of 1:25.

    Last Split Date

    n/a
    		 Mar 24, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:25

    Scores

    Altman Z-Score

    n/a
    		 -11.94

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist